Clinical Trial Update: Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease

View source ↗

Summary

The clinical trial examining percutaneous revascularization for coronary bifurcation disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Florida | Conditions: Coronary Disease | Status: TERMINATED